Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Castellino

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Immunology|December 15, 2012
Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virusFrancesca Buricchi, Monia Bardelli, Carmine Malzone, et al.
Human Vaccines & Immunotherapeutics|March 20, 2012
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adultsGiovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, et al.
Plos One|June 13, 2015
Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In VitroNico Chiappini, Rocco Cantisani, Laura Pancotto, et al.
Human Vaccines & Immunotherapeutics|April 16, 2014
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administrationGiovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, et al.
Immunological Reviews|February 16, 2008
Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imagingRonald N Germain, Marc Bajénoff, Flora Castellino, et al.
AIDS Research and Human Retroviruses|March 24, 2012
Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patientsChiara Agrati, Cristiana Gioia, Concetta Castilletti, et al.
Science Translational Medicine|April 8, 2010
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virusSurender Khurana, Wanida Chearwae, Flora Castellino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responsesFabiana Spensieri, Erica Borgogni, Luisanna Zedda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2015
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeBeatris Mastelic Gavillet, Christiane S Eberhardt, Floriane Auderset, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
Dissecting the immune response to MF59-adjuvanted and nonadjuvanted seasonal influenza vaccines in children less than three years of ageLuisanna Zedda, Eduardo Forleo-Neto, André Vertruyen, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Immunology|December 15, 2012
Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virusFrancesca Buricchi, Monia Bardelli, Carmine Malzone, et al.
Human Vaccines & Immunotherapeutics|March 20, 2012
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adultsGiovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, et al.
Plos One|June 13, 2015
Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In VitroNico Chiappini, Rocco Cantisani, Laura Pancotto, et al.
Human Vaccines & Immunotherapeutics|April 16, 2014
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administrationGiovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, et al.
Immunological Reviews|February 16, 2008
Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imagingRonald N Germain, Marc Bajénoff, Flora Castellino, et al.
AIDS Research and Human Retroviruses|March 24, 2012
Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patientsChiara Agrati, Cristiana Gioia, Concetta Castilletti, et al.
Science Translational Medicine|April 8, 2010
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virusSurender Khurana, Wanida Chearwae, Flora Castellino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responsesFabiana Spensieri, Erica Borgogni, Luisanna Zedda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2015
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeBeatris Mastelic Gavillet, Christiane S Eberhardt, Floriane Auderset, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
Dissecting the immune response to MF59-adjuvanted and nonadjuvanted seasonal influenza vaccines in children less than three years of ageLuisanna Zedda, Eduardo Forleo-Neto, André Vertruyen, et al.
Pageof 5